Speaker illustration

Professor Pieter Kamphuisen

Tergooi MC, Hilversum (Netherlands (The))

How do we assess anticoagulant activity in emergency situations in NOAC treated AF patients?

Event: ESC Congress 2018

Topic: Atrial Fibrillation (AF)

Session: Biomarker-based approaches for improved atrial fibrillation management


Practical guidance for patient-protection in the era of NOACs.

Event: ESC CONGRESS 2014

Topic: Thrombosis and coagulation

Session: Changing the face of anticoagulation: 5 years since RE-LY®


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb